Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
CD Protein Inhibitors
Products
Products
Diseases
News
«
1
2
...
13
14
15
16
17
18
19
20
21
22
23
...
27
28
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
283
566
849
1132
1415
1698
1981
2264
2547
2830
Anti-CD22 CAR NK Cells
/ Allife Medical Science and Technology
Aurixim
(rituximab conjugate) / ChemRar
B1962
/ AP Biosciences
BA1106
/ Luye Group
BA1202
/ Luye Group
BA3182
/ BioAtla
BC007
/ Guilin SanJin Group
BC008-1A
/ REMD Bio, Buchang Pharma
BC3448
/ Wuxi Biocity
BC8-SA
/ National Cancer Institute
BCMA-PD1-CART Cells
/ Chinese PLA General Hospital
BCMA-TriCAR-T
/ Timmune Biotech
BEAM-201
/ Beam Therap
BG-T19
/ Hedy Group
BGB-108
/ BeiGene
BH3120
/ Hanmi
BHV-1100
/ PeptiDream, Biohaven
BI 765128
/ Boehringer Ingelheim
BI 765179
/ Boehringer Ingelheim
BIIB063
/ Biogen
BJ-005
/ BJ Biosci
BMS-986090
/ BMS
BMS-986179
/ BMS
BMS-986358
/ BMS
BMS-986406
/ BMS
BMS-986497
/ BMS
BND-35
/ Biond Biologics
BOS-342
/ Boston Pharma
BPI-371153
/ Betta Pharma
BRL-303
/ BRL Medicine
BT-007
/ Bioceltech
BT7480
/ Bicycle Therap
BVX-20
(rituximab biosimilar) / Biocon
BYK324677
/ Takeda
BYON4413
/ Byondis
CA-170
/ Curis
CAR-CD44v6
/ Ospedale San Raffaele, AGC Biologics
CAR-NK-CD19 cells
/ Beijing Boren Hospital
CAR-T CD19
/ Sheba Medical Center
CAR-T CD19/CD20/CD22/CD30
/ Shanghai Unicar
CAR-T Targeting Igβ Targets
/ The First Affiliated Hospital of Soochow University
CAR-T19/CAR-T22 immunotherapy
/ Shenzhen BinDeBio
CAR19T2 T cells
/ Zhaotai InVivo Biomedicine
CAR20.19.22 T
/ Miltenyi Biotec, Medical College of Wisconsin
CART-138/BCMA/19/more
/ Shanghai Unicar
CART-19
/ Shanghai Unicar
CART-30
/ AbelZeta Pharma
CART-33
/ University of Pennsylvania
CART-meso-19 T cells
/ Novartis
CART20
/ Beijing Biohealthcare
«
1
2
...
13
14
15
16
17
18
19
20
21
22
23
...
27
28
»
